Skip to main content
| Hans-Günter Meyer-Thompson | Cannabis als Medizin

GW Pharma cannabis drug wins European panel OK

GW Pharma cannabis drug wins European panel OK

GW Pharmaceuticals’ marijuana-based treatment Epidiolex has won a positive recommendation for marketing approval from a European Medicines Agency (EMA) panel on Friday for use as an additional treatment for two types of seizures. (Reuters, 26.07.2019)

https://uk.reuters.com/article/uk-gw-pharma-epidiolex-ema-panel/gw-pharma-cannabis-drug-wins-european-panel-ok-idUKKCN1UL233